Clostridium Difficile-Associated Diarrhea and Colitis

Infection Control & Hospital Epidemiology

Volumn 16, Issue 8, 1995, Pages 459-477

  Gerding, Dale N ^a   Johnson, Stuart ^a   Peterson, Lance R ^b   Mulligan, Maury E ^c   Silva, Joseph ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CLOSTRIDIUM DIFFICILE CYTOTOXIN B; CLOSTRIDIUM DIFFICILE ENTEROTOXIN A; ENTEROTOXIN;

BACTERIAL INFECTION; CHEMISTRY; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE; COLITIS; CROSS INFECTION; DIARRHEA; DISEASE TRANSMISSION; FECES; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; REVIEW;

BACTERIAL TOXINS; CLINICAL PROTOCOLS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; CROSS INFECTION; DIARRHEA; ENTEROTOXINS; FECES; HUMAN; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0029354194     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.2307/30141083     Document Type: Article

References (193)

1. Lyerly D.M. H.C. Krivan T.D. Wilkins, Clostridium difficile its disease and toxins. Clin Microbiol Rev 1988;1:1-18.
2. Gerding D.N. Disease associated withClostridium difficile infection. Ann Intern Med 1989;110:255-257.
3. McFarland L.V. W.E. Stamm, Review ofClostridium difficile-associated diseases. Am J Infect Control 1986;14:99-109.
4. Siegel D.L. P.H. Edelstein, Nachamkin I Inappropriate testing for diarrheal diseases in the hospital. JAMA 1990;263:979-982.
5. Yannelli B., Gurevich I Schoch P.E., Cunha B.A. Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrhea. Am J Infect Control 1988;16:246-249.
6. McFarland L.V. M. Mulligan R.Y.Y. Kwok W.E. Stamm, Nosocomial acquisition of Closdridium difficile infection. NEngl J Med 1989;320:204-210.
7. Johnson S. C.R. Clabots F.V. Linn M.M. Olson L.R. Peterson D.N. Gerding, NosocomialClostridium difficile colonization and disease. Lancet 1990;336:97-100.
8. Fekety R., Kim K.H., Brown D., Batts D.H., Cudmore M., Silva J. Jr Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am Med 1981;70:906-908.
9. Kelly C.P. C. Pothoulakis, LaMont J.T. Clostridium difficile colitis. N Engl J Med 1994;330:257-262.
10. Gerding D.N. J.S. Brazier, Optimal methods for identifyingClostridium difficile infections. Clin Infect Dis 1993, 16(suppl 4):S439-S442.
11. Kelly P.J., Peterson L.R. The role of the clinical microbiology laboratory in the management ofClostridium difficile-associated diarrhea. Infect Dis Clin North Am 1993;7:277-293.
12. Shanholtzer C.J. K.E. Willard J.J. Holter, et al. Comparison of VIDAS C difficile toxin A immunoassay (CDA) with C difficile culture, cytotoxin, and latex test. J Clin Microbiol 1992;30:1837-1840.
13. Walker R.C. P.J. Ruane J.E. Rosenblatt, et al. Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difFicile-related enteric disease. Diagn Microbiol Infect Dis 1986;5:61-69.
14. Gerding D.N. M.M. Olson L.R. Peterson, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986;146:95-100.
15. Tedesco F.J. R.W. Barton, Alpers D.H. Clindamycin-associated colitis. Ann Intern Med 1974;81:429-433.
16. Bergstein J.M. A. Kramer D.H. Wittman C. Aprahamian E.J. Quebbeman, Pseudomembranous colitis: how useful is endoscopy? Surg Endosc 1990;4:217-219.
17. Bowman R.A. Riley T.V. Laboratory diagnosis ofClostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 1988, 7:476484.
18. Peterson L.R., Shanholtzer C.J. Laboratory methods for the diagnosis of C difficile-related gastrointestinal disease. Lab Manag 1988, 26: 4245.
19. Rolfe R.D. Diagnosis ofClostridium difficile-associated intestinal disease. CritRev Clin Lab Sci 1986;24:235-261.
20. Bartlett J.G. Antibiotic-associated colitis. Dis Mon 1984;30:1-55.
21. Knoop F.C. M. Owens I.C. Crocker, Clostridium difficile clinical disease and diagnosis. Clin Microbiol Rev 1993;6:257-265.
22. Aronsson B. R. Mollby C.E. Nord, Diagnosis and epidemiology ofClostridium difficile enterocolitis in Sweden. J Antimicrob Chemother 1984, 14(suppl D):85-95.
23. Larson H.E., Parry J.V. Price, A.B., et al. Undescribed toxin in pseudomembranous colitis. Br MedJ 1977;1: 1246-1248.
24. Bartlett J.G. Antibiotic-associated diarrhea.Clin Infect Dis 1992, 15 :573-581.
25. Borriello S.P. Wren, B.W., Hyde, S., et al. Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 1992, 60:4192-4199.
26. Lyerly D.M., Barroso L.A. Wilkins, T.D., et al. Characterization of a toxin A-negative, toxinB-positive strain of Clostridium difficile. Infect Immun 1992;60 4633-4639.
27. Torres J. E. Purification and characterization of toxin B from a strain ofClostridium difficile that does not produce toxin A. J Med Microbiol 1991, 35: 4044.
28. Doem G.Y. Coughlin, R.T., Wu, L. Laboratory diagnosis ofClostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol 1992;30:2042-2046.
29. Nachamkin I. L. Lotz-Nolan D. Skalina, Evaluation of a commercial cytotoxicity assay for detection ofClostridium difficile toxin. J Clin Microbiol 1986;23:954-955.
30. Tichota-Lee J. M.J. Jaqua-Stewart D. Benfield, et al. Effect of age on the sensitivity of cell cultures to Clostridium difficile toxin. Diagn Microbiol Infect Dis 1987;8:203-214.
31. Peterson L.R. M.M. Olson C.J. Shanholtzer, et al. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis 1988;10:85-91.
32. Delmee M., Mackey T. Hamitou A. Evaluation of a new commercialClostridium difficile toxin A enzyme immunoassay using diarrheal stools. Eur J Clin Microbiol Infect Dis 1992;11:246-249.
33. Barbut F., Kajzer C., Planas N., et al. Comparison of three enzyme immunoassays, a cytotoxicity assay and toxigenic culture for the diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 31:963-967.
34. Kurzynski T.A. Kimball, J.L., Schultz, D.A., et al. Evaluation of C diff-Cube test for detection of Clostridium difficile-associated diarrhea. Diagn Microbiol Infect Dis 1992;15:493-498.
35. Woods G.L. P.C. Iwen, Comparison of a dot immunobinding assay, latex agglutination, and cytotoxin assay for laboratory diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol. 1990, 28: 855-857
36. Borriello S.R. Vale, T, Brazier, J.S., Hyde, S., Chippeck, E Evaluation of a commercial enzyme immunoassay kit for the detection ofClostridium difficile toxin A Eur J Clin Microbiol Infect Dis 1992 11:360-363.
37. DeGirolami P.C. P.A. Hanff K. Eichelberger, et al. Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A J Clin Microbiol 1992 30:1085-1088.
38. DiPersio J.R. F.J. Varga D.L. Conwell, Kraft J.A. Kozak K.J. Willis.D.H. Development of a rapid enzyme immunoassay forClostridium difficile toxin A and its use in the diagnosis of C difficile-associated disease. J Clin Microbiol 1991;29:2724-2730.
39. Altaie S.S., Meyer R. Dryja D. Comparison of two commercially available enzyme immunoassays for detection ofClostridium difficile in stool specimens. J Clin Microbiol 1994;32:51-53.
40. Merz CSC Kramer M. Formen, et al. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxins from stool specimens. J Clin Microbiol 1994;32:1142-1147.
41. Arrow S.A. Croese, L., Bowman R.A. Riley T.V. Evaluation of three commercial enzyme immunoassay kits for detecting faecalClostridium difficile toxins. J Clin Pathol 1994;47:954-956.
42. George W.L. V.L. Sutter D. Citron, et al. Selective and differential medium for isolator of Clostridium difficile. J Clin Microbiol 1979;9:214-219.
43. Levett P.N. Effect of antibiotic concentration in a selective medium on the isolation ofClostridium difficile from faecal specimens. J Clin Pathol 1985;38:233-234.
44. Shanholtzer C.J., Peterson L.R. Laboratory quality assurance testing of microbiologic media from commercial sources, Am J Clin Pathol 1987;88:210-215.
45. Aspinall S.T. D.N. Hutchinson, New selective medium for isolatingClostridium difficile from faeces. J Clin Pathol 1992;45:812-814.
46. Bartley S.L. Jr Dowell V.R., Comparison of media for the isolation ofClostridium difficile from fecal specimens. Lab Med 1991;22:335-338.
47. Iwen P.C. S.J. Booth G.L. Woods, Comparison of media for screening of diarrheic stools for therecovery of Clostridium difficile. J Clin Microbiol 1989;27:2105-2106.
48. Mundy L.S. C.J. Shanholtzer K.E. Willard D.N. Gerding, Peterson LR Laboratory detection of Clostridium difficile: a comparison of media and incubation conditions, Am J Clin Pathol 1994, 103: 52 - 56.
49. Marler L.M., Siders J.A. Wolters L.C., Pettigrew Y., Skitt B.L., Allen S.D. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J Clin Microbiol 1992;30:514-516.
50. Peterson L.R. J.J. Holter C.J. Shanholtzer, et al. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test. Am J Clin Pathol 1986, 86: 208-211.
51. Berg J.D. R.G. Mills D.J. Coleman, Improved gasliquid chromatography method for the identification ofClostridium difficile. J Clin Pathol 1985;38:108-110.
52. Aspinall S.T. Dealler S.E. New rapid identification test forClostridium difficile. J Clin Pathol 1992; 45:956-958.
53. Bate G Comparison of Minitek Anaerobe II ®, API An-Ident ®, and Rapid ANA ® systems for identification ofClostridium difficile. Am J Clin Pathol 1986;85:716-718.
54. Gresser M.E. C.J. Shanholtzer D.N. Gerding, et al. Evaluation of the 24-h API Anaerobe System® for identification of Clostridium difficile. J Clin Microbiol 1984;19:915-916.
55. Clabots C.R. S. Johnson M.M. Olson, et al. Clostridium difficile-associated diarrhea (CDAD) diagnosis in patients with positive stool culture (CULT) and negative stool cytotoxin (CTX) assays (Abstract #1567). In:Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington, DC; 1993.
56. Lyerly D.M. T.D. Wilkins, Commercial latex test forClostridium difficile toxin A does not detect toxin A J Clin Microbiol 1986; 23: 622 - 623.
57. Lyerly D.M. L.A. Barroso T.D. Wilkins, Identification of the latex test-reactive protein ofClostridium diffficile as glutamate dehydrogenase. J Clin Microbiol 1991; 29: 2639 - 2642.
58. Wren B.W. C.L. Clayton N.B. Castledine, et al. Identification of toxigenic Clostridium difficile strains by using a toxin A gene-specific probe. J Clin Microbiol 1990;28:1808-1812.
59. Phelps C.J. D.L. Lyerly J.L. Johnson, et al. Construction and expression of the complete Clostridium difficile toxin A gene in Escherichia coli. Infect Immun 1991;59:150-153.
60. Kato N., Ou C-Y., Kato H., et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 1991; 29: 33 - 37.
61. McMillin D.E. L.L. Muldrow S.J. Laggette, et al. Simultaneous detection of toxin A and toxin B genetic determinants of Clostridium difficile using the multiplex polymerase chain reaction. Can J Microbiol 1992, 38: 81 - 83.
62. Wren B. C. Clayton S. Tabaqchali, Rapid identification of toxigenicClostridium difficile strains by polymerase chain reaction. Lancet 1990;335:423.
63. Gumerlock P.H. Y.J. Tang J.B. Weiss J. Jr Silva, Specific detection of toxigenic strains ofClostridium difficile in stool specimens. J Clin Microbiol 1993; 31: 507 - 511.
64. Kuhl S.J. Y.J. Tang L. Navarro P.H. Gummerlock J. Jr Silva, Diagnosis and monitoring ofClostridium difficile infections with the polymerase chain reaction. Clin Infect Dis 1993, 16(suppl 4):S234-S238.
65. Levine H.G. M. Kennedy, LaMont J.T. Counterimmunoelectrophoresis vs cytotoxicity for the detection ofClostridium difficile toxin. J Infect Dis 1982, 145: 398.
66. Madan E. M. Slifkin, Stool caproic acid for screening ofClostridium difficile. Am J Clin Pathol 1988;89:525-527.
67. Shanholtzer C.J. L.R. Peterson M.M. Olson, et al. Prospective study of Gram-stained stool smears in diagnosis of Clostridium difficile colitis. J Clin Microbiol 1983;17:906-908.
68. West S.E.H. T.D. Wilkins, Problems associated with counterimmunoelectrophoresis assays for detectingClostridium difficile toxin. J Clin Microbiol 1982; 15: 347 - 349.
69. Hall I.C., O’Toole E Intestinal flora in new-born infants. Am J Dis Child 1935;49:390-402.
70. Hafiz S. C.L. Oakley, Clostridium difficile: isolation and characteristics. JMed Microbiol 1976;9:129-136.
71. Finney J.M. Gast-enterostomy for cicatrizing ulcer of the pylorus. Johns Hopkins Hosp Bull 1893;11:53-55.
72. Bartlett J.G. T.W. Chang M. Gurwith S.L. Gorbach, Onderdonk A.B. Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia. N Engl J Med 1978, 298: 531-543
73. Larson H.E. Honour P. Price A.B., Borriello S.P. Clostridium difficile and the etiology of pseudomembranous colitis. Lancet 1978;1: 1063-1066.
74. Viscidi R.S. Wiley J.G. Bartlett, Isolation rates and toxigenic potential ofClostridium difficile isolates from various patient populations. Gastroenterology 1981;81:5-9.
75. Mollby Aronsson B., Nord C-E. Antimicrobial agents andClostridium difficile in acute enteric disease: epidemiologic data from Sweden, 198(11982. J Infect Dis 1985, 151:476-481
76. Nakamura S. M. Mikawa M. Takabatake, et al. Isolation of Clostridium difficile from the feces and antibody in sera of young and elderly adults. Microbiol Immunol 1981, 25:345351.
77. Larson H.E. F.E. Barclay, Honour P., Hill I.D. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982;146:727-733.
78. Burdon D.W. Clostridium difficile: the epidemiology and prevention of hospital-acquired infection. Infection 1982;10:203-204.
79. Toshniwal R. Jr. Silva J. R. Fekety, Kim K.-H. Studies on the epidemiology of colitis due toClostridium difficile in hamsters. J Infect Dis 1981, 143 :51-54.
80. Larson H.E. A.B. Price, Borriello S.P. Epidemiology of experimental enterocolitis due to Clostridium difficile. J Infect Dis 1980;42:408-413.
81. Greenfield C. J.R. Aguilar Ramirez R.E. Pounder, etal. Clostridium difficile and inflammatory bowel disease. Gut 1983;24:713-717.
82. Bender B.S. R. Bennett B.E. Laughon, et al. Is Clostridium difficile endemic in chronic care facilities? Lancet 1986;2: 11-13.
83. Yablon S.A. Krotenberg, R., Fruhmann, K., Clostridium difficile-related disease: evaluation and prevalence among inpatients with diarrhea in two freestanding rehabilitation hospitals. Arch Phys Med Rehabil 1993, 74: 913.
84. Hirschhom L.R., Trnka Y. Onderdonk A. Lee M.-L.T. Platt R. Epidemiology of community-acquired Clostridium difficileu-associated diarrhea. J Infect Dis 1994;169:127-133.
85. Akhtar S.Q. Isolation ofClostridium difficile from diarrhea patients in Bang 1 adesh. JTrop Med Hyg 1987;90:189192.
86. Ayyagari A., Sharma P., Venkateswarlu M.S. Mehta S., Agarwal K.C. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India. J Diarrhoeal Dis Res 1986;4:157-160.
87. Pear S. T. Williamson K. Bettin D.N. Gerding J.N. Galgiani, Decrease in nosocomialClostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994;120:272-277.
88. Yee J. C.M. Dixon A.P.H. McLean J.L. Meakins, Clostridium difficile disease in a department of surgery: the significance of prophylactic antibiotics. Arch Surg 1991;126:241-246.
89. Anand A., Glatt A.E. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993;17:109-113.
90. Pierce P.F. Jr, Wilson, R., Silva J. Jr, et al. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 1982;145:269-274.
91. McFarland L.V. C.M. Surawicz W.E. Stamm, Risk factors forClostridium difficile carriage and Clostridium difficile-associated diarrhea in a cohort of hospitalized patients J Infect Dis 1990;162:678-684.
92. Milligan D.W. J.K. Kelly, Pseudomembraneous colitis in a leukaemia unit: a report offive total cases. J Clin Pathol 1979, 32: 1237 - 1243.
93. Barbut F. Depitre C., Delmee M., Corthier G., Petit J.C. Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency vims-negative patients. J Clin Microbiol 1993; 31: 740 - 742.
94. Roberts M.C. L.Y. McFarland, Mullany P., Mulligan M.E. Characterization of the genetic basis of antibiotic resistance in Clostridium difficile. J Antimicrob Chemother 1994;33:419-429.
95. McFarland L.V. G.W. Elmer W.E. Stamm M.E. Mulligan, Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations ofClostridium difficile infection in a cohort of hospitalized patients. Infect Immun 1991;59:2456-2462.
96. Peach S.L., Borriello S.P. Gaya, F.E., et al. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol 1986;39:1013-1018.
97. Wamy M., Vaerman J.-P., Avesani V., Delmee M Human antibody response toClostridium dificile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384-389.
98. Mulligan M.E. S.D. Miller, McFarland L.Y. Fung, H.C., Kwok, R.Y.Y. Elevated levels of serum immunoglobulins in asymptomatic carriers ofClostridium difficile. Clin Infect Dis 1993; 16;239-244.
99. Johnson S. D.N. Gerding E.N. Janoff, Systemic and mucosal antibody responses to toxin A in patients infected withClostridium difficile. J Infect Dis 1992;166:1287-1294.
100. Kelly CP, Pothoulakis C, Orellana J, LaMont JT Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 1992;102:3540.
101. Samore M.H. K.M. Bettin P.C. DeGirolami, et al. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis 1994;170:615-621.
102. Johnson S. A. Adelnann C.R. Clabots, Peterson L.R., Gerding D.N. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989;159:340-343.
103. O’Neill G.L. M.H. Beaman, Riley T.V. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991;107:627-635.
104. Clabots C.R. S. Johnson M.M. Olson L.R. Peterson D.N. Gerding, Acquisition ofClostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:561-567.
105. Heard S.R. B. Wren M.J. Barnett J.M. Thomas S. Tabaqchali, Clostridium difficile infection in patients with haematological malignant disease. Epidemiol Infect 1988;100:63-72.
106. Clabots C.R. L.H. Peterson D.N. Gerding, Characterization of a nosocomialClostridium difficile outbreak by using plasmid profile typing and clindamycin susceptibility testing. J Infect Dis 1988;158:731-736.
107. Johnson S.D. N. Gerding M.M. Olson, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990;88:137-140.
108. Malamou-Ladas H. S.O. Farrell J.O. Nash S. Tabaqchali, Isolation ofClostridium difficile from patients and the environment of hospital wards. J Clin Pathol 1983, 6:8&92.
109. Mulligan M.E. R.D. Rolfe S.M. Finegold, George W.L. Contamination of a hospital environment by Clostridium difficile. Curr Microbiol 1979, 3 :173-175.
110. Savage A.M. R.H. Alford, Nosocomial spread ofClostridium difficile. Infect Control 1983;4:31-33.
111. Brooks S.E. R.O. Veal M. Kramer L. Dore N. Schupf M. Adachi, Reduction in the incidence ofClostridium difficile-associated diarrhea in an acute care hospital and a skilled nursing facility following replacement of electronic thermometers with single-use disposables. Infect Control Hosp Epidemiol 1992, 13: 98-103.
112. Brooks S. R. Real M. Kramer M. Adachi, Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 1990, 11: 574.
113. Mogg G.A.G. M.R.B. Keighly D.W. Burdon, et al. Antibiotic associated colitis-a review of 66 cases. Br J Surg 1979; 66:738-742.
114. Gurian L.T. T. Ward R.M. Katon, Possible foodbome transmission in a case of pseudomembranous colitis due toClostridium difficile. Gastroenterology 1982;83:465-469.
115. Oishi J.S. M.E. Mulligan S.M. Finegold, Failure to detectClostridium difficile in foods. J Infect Dis 1983, 148: 360.
116. Kim K.-H. Fekety R., Batts D.H., et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic associated colitis. J Infect Dis 1981;143:42-50.
117. Borriello S.P. Honour P., Turner T., Barclay E Household pets as a potential reservoir for Clostridium difficile infection. J. Clin Pathol 1983;36:84-87.
118. Riley T.V. Adams, J.E., O’Neill G.L., Bowman R.A. Gastrointestinal carriage ofClostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect 1991;107:659-665.
119. Hafiz S. R.S. Morton M.G. McEntegart S.A. Waitkins, Clostridium difficile in the urogenital tract of males and females. Lancet 1975;1: 420 - 421.
120. Al-Jumaili U.M. Shibley A.H. Iishmann C.O. Record, Incidence and origin ofClostridium difficile in neonates J Clin Microbiol 1984; 19: 77 - 78.
121. Clabots C.R. S. Johnson K.M. Bettin, et al. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol 1993;31:1870-1876.
122. Wolfhagen M.J.H.M. Fluit A.C., Torensma R., et al. Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol 1993; 31: 2208 - 2211.
123. Tabaqchali S. Epidemiologic markers of Clostridiumdifficile. Rev Infect Dis 1990, 12(suppl 2):S192-S198.
124. Tabaqchali S. D. Holland S. O’ Farrell, Sitman R. Typing scheme for Clostridium difficile. Its application in clinical and epidemiological studies. Lancet 1984;1:935-938.
125. Poxton I.R. B. Aronsson R. Molby C.E. Nord J.G. Collee, Immunochemical fingerprinting ofClostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhea. J Med Microbiol 1984; 17:317-324.
126. Mulligan M.E. L.R. Peterson R.Y.Y. kwong C.R. Clabots D.N. Gerding, Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typingClostridium difficile. J Clin Microbiol 1988;26:41-46.
127. Kato H. J.J. Cavallaro, Kato N., et al. Typing of Clostridium difficile by western immunoblotting with 10 different antisera. J Clin Microbiol 1993;31:413-415.
128. Delmee M. V. Avesani, Delferriere, Burtonboy G. Characterization of flagella ofClostridium difficile and their role in serogrouping reactions. J Clin Microbiol 1990;28:2210-2214.
129. Sell T.L. D.R. Schaberg, Fekety F.R. Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol 1983, 17: 1147-1151 152.
130. Dei R Observations on phage-typing ofClostridium difficile: preliminay evaluation of a phage panel. Eur J Epidemiol 1989, 5: 351 - 354.
131. Bowman R.A. O’Neill G.L., Riley T.V. Non-radioactive restriction fragment length polymorphism (RFLP) typing ofClostridium difficile. FEMS Microbiol Lett 1991;63:269-272.
132. Kristjansson M. M.H. Samore D.N. Gerding, et al. Molecular differentiation of Clostridium difficile: a comparison of restriction endonuclease analysis, ribotyping. and pulsed field gel electrophoresis. J Clin Microbiol 1994;32:1963-1969.
133. McMillin D.E. L.L. Muldrow, Typing of toxic strains ofClostridium difficile using DNA fingerprints generated with arbitrary polymerase chain reaction primers. FEMS Microbiol Lett 1992;71:5-9.
134. Wren B.W. R. Heard Al al-Saleh S. Tabaqchali, Characterization ofClostridium difficile strains by polymerase chain reaction with toxin Aand B- specific polymers. J Med Microbiol 1993;38:109-113.
135. Silva J. Jr, Tang Y.J., Gumerlock P.H. Genotyping of Clostridium difficile isolates. J Infect Dis 1994; 169:661-664.
136. Bettin K.C. Clabots P. Mathie K. Willard D. N. Gerding, Effectiveness of soap vs. chlorhexidine gluconate for the removal ofClostridium difficile from bare hands and gloved hands. Infect Control Hosp Epidemiol 1994;15:697-702.
137. Nolan N.P.M., Kelly C.R. Humphreys, J.F.H., et al. An epidemic of pseudomembranous colitis: importance of person-to-person spread. Gut 1987;28:1467-1473.
138. Brown E. G.M. Talbot, Axelrod B. Provencher M., Hoegg C. Risk factors forClostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990, 11: 283 - 290.
139. Wilcox M.H. R.C. Spencer, Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 1992;22:85-92.
140. Struelens M.J. A. Maas C. Nonhoff, et al. Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991, 91(suppl 3B): 1385-1445.
141. Olson M.M. MT Shanholtzer Jr Lee J.T. D.N. Gerding, Ten years of prospectiveClostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982 – 1991. Infect Control Hosp Epidemiol 1994, 15: 371 - 381.
142. Hughes C.E. R.L. Gebhard L.R. Peterson D.N. Gerding, Efficacy of routine fiberoptic endoscope cleaning and disinfection for killingClostridium difficile. Gastrointest Endosc 1986;32:7-9.
143. Rutala W.A., Gergen M.E. Weber, D.J. Inactivation ofClostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 1993, 14 :3&39.
144. Kaatz G.W. S.D. Gitlin D.R. Schaberg, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-1294.
145. Delmee M.B. Vandercam V. Avesani J.L. Michaux, Epidemiology and prevention ofClostridium difficile infections in a leukemia unit. Eur J Clin Microbiol 1987;6:623-627.
146. Samore M.H. P.C. DeGirolami A. Tlucko D.A. Lichtenberg Z.A. Melvin A.W. Karchmer, Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994;18:181-187.
147. Kerr R.B. D.I. McLaughlin L.W. Sonnenberg, Control ofClostridium difficile colitis outbreak by treating asymptomatic carriers with metronidazole. Am J Infect Control 1990;18:332-335.
148. Hoverstad T. Carlstedt-Duke B., Lingaas E., et al. Influence of ampicilliln, clindamycin, and mnetronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 1986;21:621-628.
149. Arabi Y. Dimock F. D.W. Burdon J. Alexander-Willliams, Keighley M.R.B. Influence of neomycin and metronidazole on colonic microflora of volunteers. J Antimicrob Chemother 1979;5:531-537.
150. Johnson S. S.R. Homann K.M. Bettin, et al. Treatment of asymptomatic Clostridium dificile carriers (fecal excretors) with vancomycin or metronidazole. Ann Intern Med 1992;117:297-302.
151. Bartlett J.G. Antimicrobial agents implicated in Clostridium difficile toxin associated diarrhea or colitis. Johns Hopkins Med J 1981;149:6-9.
152. Surawicz C.M. G.W. Elmer P. Speelman L.V. McFarland J. Chinn G.Van Belle, Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989;96:981-988.
153. Lyerly D.M., Bostwick E.F. Binion, S.B., Wilkins T.D. Passive immunization of hamsters against disease caused by Clostridium didficile by use of bovine immunoglobulin G concentrate. Infect Immun 1991;59:2215-2218.
154. Davidson G.F. Daniels E., Nunan H., et al. Passive immunization of children with bovine colostrum containing antibodies to human rotavims. Lancet 1989;2:709-712.
155. Tacket C.O. G. Losonsky H. Link, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coll N Engl J Med 1988 318:1240-1243.
156. Reid G.A. W. Bmce J.A. McGroarty, Cheng K.-J. Costerton J.W. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-344.
157. Siitonen S. Vapaatalo H. Salminen S., et al. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhea. Ann Intern Med 1990:22:57059.
158. Gorbach S Lactic acid bacteria and health. Ann Intern Med 1990;22:37-41.
159. Kotz C.M. L.R. Peterson J.A. Moody D.A. Savaiano M.D. Levitt, Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters. Dig Dis Sci 1992;37:129-132.
160. Teasley D.G. Gerding D.N., Olson M.M., et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhea and colitis. Lancet 1983;2:1043-1046.
161. Bartlett J.G. The 10 most common questions aboutClostridium difficile-associated diarrhea/colitis. Infect Dis Clin Pract 1992;1:254-259.
162. Kleinfeld D.I. R.J. Sharpe, Donta S.T. Parenteral therapy for antibiotic-associated pseudomembranous colitis. J Infect Dis 1988, 157: 389.
163. Bolton R.P. Culshaw, M.A. Fecal metronidazole concentrations during oral and intravenous therapy for antibiotic-associated colitis due toClostridium difficile. Gut 1986;27:1169-1172.
164. Peterson L.R. Gerding D.N. Antimicrobial agents inClostridium difficile-associated intestinal disease. In: Rambaud J-C, Ducluzeau R, eds.Clostridium difficile-Associated Intestinal Diseases. Paris, France: Springer-Verlag; 1990:115-127.
165. George W.L. Rolfe R.D., Finegold S.M. Treatment and prevention of antimicrobial agent-induced colitis and diarrhea. Gastroenterology 1980;79:366-372.
166. Cone J.B., Wetzel W Toxic megacolon secondary to pseudomembranous colitis. Dis Colon Rectum 1982;25:478-482.
167. Finegold S.M. WL George, Therapy directed againstClostridium difficile and its toxins: complications of therapy. In: Rolfe RD, George WL, eds. Clostridium difficile: Its Role in Intestinal Disease. New York, New York: Academic Press: 1988:341-357.
168. Silva J. Jr. Batts D.H., Fekety R., Plouffe J.F., Rifkin G.D., Baird I Treatment of Clostridium dificile colitis and diarrhea with vancomycin. Am J Med 1981;71:815-822.
169. Ings R.M., McFadzean J.A. Ormerod W.E. The fate of metronidazole and its implications in chemotherapy. Xenobiotica 1975;5:223-235.
170. Fekety R., Shah AB Diagnosis and treatment ofClostridium difficile colitis. JAMA 1993;269:71-75.
171. Fekety R. J. Silva C. Kauffman B. Buggy G. Deery, Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989;86:15-19.
172. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistant-e. Infect Control Hosp Epidemiol 1995, 16: 105-113.
173. deLalla F. R. Nicolin E. Rinaldi, et al. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium dififcile-associated diarrhea. Antimicrob Agents Chemother 1992;36:2192-2196.
174. Dudley M.N. J.C. McLaughlin G. Carrington J. Frick C.H. Nightingale R. Quintiliani, Oral bacitracin versus vancomycin therapy forClostridium difficile-induced diarrhea: a randomized, double-blind trial. Arch Intern Med 1986;146:1101-1104.
175. Young G.P. P.B. Ward N. Bay ley, et al. Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology 1985;89:1038-1045.
176. Mogg G.A. G.Y. Arabi D. Youngs, et al. Therapeutic trials of antibiotic associated colitis. Scand J Infect Dis 1980;(suppl 22):41-45.
177. Levett P.N. Time-dependent killing ofClostridium difficile by metronidazole and vancomycin. J Antimicrob Chemother 1991;27:55-62.
178. Surawicz C.M. L.V. McFarland G. Elmer J. Chin, Treatment of recurrentClostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989, 84: 1285 - 1287.
179. Buggy B.E. Fekety, R., Silva J. Jr Therapy of relapsingClostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987, 9: 155-159.
180. Gorbach S.L. T.W. Chang B. Goldin, Successful treatment of relapsingClostridium dificile colitis with lactobacillus GG. Lancet 1987;2:1519.
181. Moncino M.D. J.M. Falletta, Multiple relapses ofClostridium difficile-associated diarrhea in a cancer patient: successful control with long-term cholestyramine therapy. Am J Pediatr Hematol Oncol 1992, 14: 361 - 364.
182. Pruksananonda F.J., Powell KR Multiple relapses ofClostridium difficile-associated diarrhea responding to an extended course of cholestyramine. Pediatr Infect Dis J 1989, 8: 175-178.
183. Tvede M. J. Rask-Madsen, Bacteriotherapy for chronic relapsingClostridium difficile diarrhea in six patients. Lancet 1989;1: 1156-1160.
184. Seal D., Borriello S.F.: Barclay F., Welch A., Piper M., Bonnycastle M. Treatment of relapsingClostridium difficile diarrhea by administration of a non-toxigenic strain. Eur J Clin Microbiol 1987;6:51-53.
185. Tedesco F.J. D. Gordon W.C. Fortson, Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985, 80: 867 - 868.
186. McFarland L.V. C.M. Surawicz R.N. Greenberg, et al. Randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Amer Med Worn Assoc 1994;271:1913-1918.
187. Leung D.Y.M. C.P. Kelly M. Boguniewicz C. Pothoulakis, LaMont J.T. Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced byClostridium difficile toxin. J Pediatr 1991;118:633-637.
188. Morris J.B. R.M. Zollinger, Stellato T.A. Role of surgery in antibiotic-induced pseudomembranous colitis. Am J Surg 1990;160:535-539.
189. Silva J. Jr. Update on pseudomembranous colitis. West J Mcdl 1989;151:644-648.
190. Nath S.K. Thornley J.H., Kelly M., et al. A sustained outbreak of Clostridium difficile in a general hospital: persistence of a toxigenic clone in four units. Infect Control Hosp Epidemiol 1994, 15: 382 - 389.
191. Silva J. Jr Clostridium difficile nosocomial infections-still lethal and persistent. Infect Control Hosp Epidemiol 1994, 15: 368 - 370.
192. Gross P.A. T.L. Barret, Dellinger E.P. et al. Consensus development of quality standards. Infect Control Hosp Epidemiol 1994, 15 :18 181.
193. Bartlett J.G. Treatment ofClostridium difficile colitis. Gastroenterology 1985;89:1192-1195.